These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 36348031)

  • 1. Cauda equina neuroendocrine tumors show biological features distinct from other paragangliomas and visceral neuroendocrine tumors.
    Soukup J; Manethova M; Kohout A; Soukup T; Dvorakova R; Drugda J; Vitovcova B; Gabalec F; Kaiser M; Kanta M; Kasparova P; Kozak J; Michnova L; Netuka D; Reguli S; Rychly B; Trnkova M; Vachata P; Wozniakova M; Cesak T
    Virchows Arch; 2023 Feb; 482(2):325-338. PubMed ID: 36348031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cauda Equina Neuroendocrine Tumors: Distinct Epithelial Neuroendocrine Neoplasms of Spinal Origin.
    Asa SL; Mete O; Schüller U; Ramani B; Mirchia K; Perry A
    Am J Surg Pathol; 2023 Apr; 47(4):469-475. PubMed ID: 36543154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SDH-B, INSM1, and GATA3 expression in cauda equina neuroendocrine tumors: report on 21 cases from a North indian tertiary care center.
    Sood R; Chatterjee D; Bhardwaj S; Singla N; Ahuja C; Radotra B
    Hum Pathol; 2023 Jul; 137():18-24. PubMed ID: 37100233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular characterization of CNS paragangliomas identifies cauda equina paragangliomas as a distinct tumor entity.
    Schweizer L; Thierfelder F; Thomas C; Soschinski P; Suwala A; Stichel D; Wefers AK; Wessels L; Misch M; Kim HY; Jödicke R; Teichmann D; Kaul D; Kahn J; Bockmayr M; Hasselblatt M; Younsi A; Unterberg A; Knie B; Walter J; Al Safatli D; May SA; Jödicke A; Ntoulias G; Moskopp D; Vajkoczy P; Heppner FL; Capper D; Hartmann W; Hartmann C; von Deimling A; Reuss DE; Schöler A; Koch A
    Acta Neuropathol; 2020 Dec; 140(6):893-906. PubMed ID: 32926213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical distinction of paragangliomas from epithelial neuroendocrine tumors-gangliocytic duodenal and cauda equina paragangliomas align with epithelial neuroendocrine tumors.
    Mamilla D; Manukyan I; Fetsch PA; Pacak K; Miettinen M
    Hum Pathol; 2020 Sep; 103():72-82. PubMed ID: 32668278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hand2 Immunohistochemistry in the Diagnosis of Paragangliomas and Other Neuroendocrine Neoplasms.
    Soukup J; Manethova M; Stejskal V; Novakova M; Duskova J; Hornychova H; Hacova M; Staniczkova-Zambo I; Zelinka T; Kosak M; Cesak T; Netuka D; Ryska A; Gabalec F
    Endocr Pathol; 2024 Mar; 35(1):14-24. PubMed ID: 38416360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cauda equina neuroendocrine tumor: a report of three cases and review of the literature with focus on differential diagnosis and postoperative management.
    Fabbrocini L; Zin F; Keyvani K; Ebner FH
    Neurosurg Rev; 2024 Apr; 47(1):166. PubMed ID: 38632184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The immunohistochemical, DNA methylation, and chromosomal copy number profile of cauda equina paraganglioma is distinct from extra-spinal paraganglioma.
    Ramani B; Gupta R; Wu J; Barreto J; Bollen AW; Tihan T; Mummaneni PV; Ames C; Clark A; Oberheim Bush NA; Butowski N; Phillips D; King BE; Bator SM; Treynor EC; Zherebitskiy V; Quinn PS; Walker JB; Pekmezci M; Sullivan DV; Hofmann JW; Sloan EA; M Chang S; Berger MS; Solomon DA; Perry A
    Acta Neuropathol; 2020 Dec; 140(6):907-917. PubMed ID: 32892244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overview of the 2022 WHO Classification of Paragangliomas and Pheochromocytomas.
    Mete O; Asa SL; Gill AJ; Kimura N; de Krijger RR; Tischler A
    Endocr Pathol; 2022 Mar; 33(1):90-114. PubMed ID: 35285002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Locally invasive giant spinal paraganglioma.
    Yi Chen B; Jose Mizrahi C; Yang Y; Kavar B
    J Clin Neurosci; 2020 Aug; 78():430-432. PubMed ID: 32334958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paraganglioma of the cauda equina: A clinicopathologic study of 12 cases with demonstration of cytokeratin positivity.
    Zhang Y; Du Z; Xiong J; Wang Y; Yin B
    Ann Diagn Pathol; 2022 Apr; 57():151887. PubMed ID: 35033938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokeratins expression in paragangliomas of the cauda equina.
    Labrousse F; Leboutet MJ; Petit B; Paraf F; Boncoeur-Martel MP; Moreau JJ; Catanzano G
    Clin Neuropathol; 1999; 18(4):208-13. PubMed ID: 10442464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paraganglioma of the cauda equina region.
    Corinaldesi R; Novegno F; Giovenali P; Lunardi T; Floris R; Lunardi P
    Spine J; 2015 Mar; 15(3):e1-8. PubMed ID: 25452014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cauda equina neuroendocrine tumors: A single institutional imaging review of cases over two decades.
    Ajmera P; Agarwal AK; Mehta PM; Benson JC; Madhavan AA; Diehn FE; Soni N; Bathla G
    Neuroradiol J; 2024 Feb; 37(1):84-91. PubMed ID: 37933451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paraganglioma of the cauda equina. A case report and review of the literature.
    Bak J; Olsson Y; Grimelius L; Spännare B
    APMIS; 1996 Mar; 104(3):234-40. PubMed ID: 8611199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Paraganglioma of the cauda equina region: Report of 9 cases].
    Seidou F; Tamarit C; Sevestre H
    Ann Pathol; 2020 Nov; 40(6):436-441. PubMed ID: 32331813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paragangliomas in the cauda equina region: clinicopathoradiologic findings in four cases.
    Yang SY; Jin YJ; Park SH; Jahng TA; Kim HJ; Chung CK
    J Neurooncol; 2005 Mar; 72(1):49-55. PubMed ID: 15803375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phox2B is a sensitive and reliable marker of paraganglioma-Phox2B immunohistochemistry in diagnosis of neuroendocrine neoplasms.
    Manethova M; Gerykova L; Faistova H; Drugda J; Hacova M; Hornychova H; Ryska A; Gabalec F; Soukup J
    Virchows Arch; 2023 Apr; 482(4):679-686. PubMed ID: 36656393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary Paraganglioma of the Spine: A Systematic Review of Clinical Features and Surgical Management in Cauda Equina versus Non-Cauda Equina Lesions.
    Palmisciano P; Sagoo NS; Haider AS; Ogasawara C; Ogasawara M; Bin Alamer O; Heidari KS; Raj KM; Scalia G; Umana GE; Krishnaney AA; Aoun SG; Passias PG; Vira S
    World Neurosurg; 2022 May; 161():190-197.e20. PubMed ID: 35123022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overview of the 2022 WHO Classification of Neuroendocrine Neoplasms.
    Rindi G; Mete O; Uccella S; Basturk O; La Rosa S; Brosens LAA; Ezzat S; de Herder WW; Klimstra DS; Papotti M; Asa SL
    Endocr Pathol; 2022 Mar; 33(1):115-154. PubMed ID: 35294740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.